Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1265 - 1272 of 12015 results
All OCR Enforcement Waivers Expired; Are Your Telehealth Services HIPAA Compliant?
November 9, 2023| News
More People Are Bringing Politics, Religion to Workplace, Testing Employers on Civility
November 8, 2023| News
Keeping Tabs On Fight Over Board Diversity Rule At 5th Circ.
November 8, 2023| News
California Health Care Legislative Update: Fall 2023
November 7, 2023| Blog| Viewpoint
White House Issues Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence
November 7, 2023| Blog| Viewpoint
Retirement Pros Sound Off On DOL’s New Fiduciary Rule
November 7, 2023| News
HHS Proposes Appropriate Disincentives for Health Care Providers That Commit Information Blocking
November 6, 2023| Blog| Viewpoint
US-Canada Critical Mineral, EV Battery, and Semiconductor Cross-Border Supply Chain Issues
November 6, 2023| Article| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|